Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1243-1247

  Mendes, Rodrigo E ^a   Flamm, Robert K ^a   Hogan, Patricia A ^b   Ross, James E ^a   Jones, Ronald N ^a,c  

^a JMI LABORATORIES   (United States)

^b PFIZER INC   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENCY; DRUG SENSITIVITY; DRUG SURVEILLANCE PROGRAM; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SAMPLING; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; THERAPY RESISTANCE; UNITED STATES;

ACETAMIDES; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; EPIDEMIOLOGICAL MONITORING; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; UNITED STATES;

EID: 84893458897     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02112-13     Document Type: Article

References (22)

1. Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J. 2012. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin. Infect. Dis. 54:621-629. http://dx.doi.org/10.1093/cid/cir895.
2. Shorr AF, Kunkel MJ, Kollef M. 2005. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies. J. Antimicrob. Chemother. 56:923-929. http://dx.doi.org/10.1093/jac/dki355.
3. Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B. 2002. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin. Infect. Dis. 34:1481-1490. http://dx.doi.org/10.1086/340353.
4. Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C. 2005. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 49:2260-2266. http://dx.doi.org/10. 1128/AAC.49.6.2260-2266.2005.
5. Flamm RK, Farrell DJ, Mendes RE, Ross JE, Sader HS, Jones RN. 2012. LEADER Surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers). Diagn. Microbiol. Infect. Dis. 74:54-61. http://dx.doi.org/10.1016/j. diagmicrobio.2012.05.012.
6. Flamm RK, Mendes RE, Ross JE, Sader HS, Jones RN. 2013. Linezolid surveillance results for the United States: LEADER Surveillance Program 2011. Antimicrob. Agents Chemother. 57:1077-1081. http://dx.doi.org/10.1128/AAC.02112- 12.
7. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 9th ed. Document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Mendes RE, Deshpande LM, Kim J, Myers D, Ross JE, Jones RN. 2013. Streptococcus sanguinis displaying a cross resistance phenotype to several ribosomal RNA targeting agents. Antimicrob. Agents Chemother. 51: 2728-2731. http://dx.doi.org/10.1128/JCM.00757-13.
9. Mendes RE, Deshpande LM, Bonilla HF, Schwarz S, Huband MD, Jones RN, Quinn JP. 2013. Dissemination of a pSCFS3-like cfr-carrying plasmid in Staphylococcus aureus and Staphylococcus epidermidis clinical isolates recovered from hospitals in Ohio. Antimicrob. Agents Chemother. 57:2923-2928. http://dx.doi.org/10.1128/AAC.00071-13.
10. Mendes RE, Deshpande LM, Farrell DJ, Spanu T, Fadda G, Jones RN. 2010. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J. Antimicrob. Chemother. 65:2329-2335. http://dx.doi.org/10.1093/jac/dkq331.
11. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing: 23rd informational supplement. Document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Jones RN, Ross JE, Castanheira M, Mendes RE. 2008. United States resistance surveillance results for linezolid (LEADER Program for 2007). Diagn. Microbiol. Infect. Dis. 62:416-426. http://dx.doi.org/10.1016/j.diagmicrobio. 2008.10.010.
13. Farrell DJ, Mendes RE, Ross JE, Jones RN. 2009. Linezolid surveillance program results for 2008 (LEADER Program for 2008). Diagn. Microbiol. Infect. Dis. 65:392-403. http://dx.doi.org/10.1016/j.diagmicrobio.2009.10.011.
14. Farrell DJ, Mendes RE, Ross JE, Sader HS, Jones RN. 2011. LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from the United States (56 medical centers). Antimicrob. Agents Chemother. 55:3684-3690. http://dx.doi.org/10.1128/AAC.01729-10.
15. Jones RN, Fritsche TR, Sader HS, Ross JE. 2007. LEADER surveillance program results for 2006: An activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Diagn. Microbiol. Infect. Dis. 59:309-317. http://dx.doi.org/10.1016/j.diagmi crobio.2007.06.004.
16. EUCAST. 2013. Breakpoint tables for interpretation of MICs and zone diameters. version 3.1, February 2013. http://www.eucast.org/clinical- breakpoints/. Accessed August 2013.
17. Toh SM, Xiong L, Arias CA, Villegas MV, Lolans K, Quinn J, Mankin AS. 2007. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol. Microbiol. 64:1506-1514. http://dx.doi.org/10.1111/j. 1365-2958.2007.05744.x.
18. Meka VG, Gold HS. 2004. Antimicrobial resistance to linezolid. Clin. Infect. Dis. 39:1010-1015. http://dx.doi.org/10.1086/423841.
19. Meka VG, Pillai SK, Sakoulas G, Wennersten C, Venkataraman L, DeGirolami PC, Eliopoulos GM, Moellering RC, Jr, Gold HS. 2004. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J. Infect. Dis. 190:311-317. http://dx.doi.org/10.1086/421471.
20. Herrero IA, Issa NC, Patel R. 2002. Nosocomial spread of linezolidresistant, vancomycin-resistant Enterococcus faecium. N. Engl. J. Med. 346: 867-869. http://dx.doi.org/10.1056/NEJM200203143461121.
21. Sanchez Garcia M, De la Torre MA, Morales G, Pelaez B, Tolon MJ, Domingo S, Candel FJ, Andrade R, Arribi A, Garcia N, Martinez Sagasti F, Fereres J, Picazo J. 2010. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 303:2260-2264. http://dx.doi.org/10.1001/jama. 2010.757.
22. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis